慢性乙肝病毒感染各阶段患者外周血单个核细胞中IL-22mRNA的表达水平及其临床意义

doi:10.13481/j.1671-587x.20160325

摘要/Abstract

摘要：

目的: 分析慢性乙型病毒性肝炎(CHB)、慢加急性/亚急性重型肝炎(重型肝炎)、乙肝肝硬化和乙型肝炎病毒(HBV)相关性原发性肝癌(HCC)患者外周血单个核细胞(PBMCs)中白细胞介素22(IL-22)mRNA的表达水平及其可能的临床意义。方法: 收集20名健康对照者(健康对照组)、33例CHB中度患者(CHB中度组)、21例CHB重度患者(CHB重度组)、16例重型肝炎患者(重型肝炎组)、16例乙肝肝硬化患者(肝硬化组)和40例HCC患者(HCC组)的临床资料。RT-PCR半定量分析各组研究对象PBMCs中IL-22mRNA表达水平;Pearson相关分析法分析IL-22mRNA表达水平与临床重要检测指标的相关性。结果: CHB中度、CHB重度和肝硬化组患者PBMCs中IL-22mRNA表达水平均高于健康对照组(P<0.001);重型肝炎组患者PBMCs中IL-22mRNA表达水平与健康对照组比较差异无统计学意义(P=0.830);HCC组患者PBMCs中IL-22mRNA表达水平明显低于健康对照组(P<0.001)。CHB重度组患者和重型肝炎组患者PBMCs中IL-22mRNA表达水平与总胆红素(TB)水平呈明显负相关关系(r=-0.383,P=0.043;r=-0.619,P=0.028);HCC组患者PBMCs中IL-22mRNA表达水平与血清甲胎蛋白(AFP)水平呈明显正相关关系(r=0.664,P=0.000)。结论: 慢性乙肝重症化过程中,患者PBMCs中IL-22mRNA表达水平低下提示肝细胞再生障碍,且IL-22mRNA表达水平与TB一样能够反映患者病情严重程度。IL-22可能对HCC的发生发展起促进作用。

关键词: 白细胞介素22, 肝炎, 乙型, 慢性, 肝肿瘤

Abstract:

Objective: To detect the expression levels of IL-22 mRNA in peripheral blood mononuclear cells (PBMCs) of the patients with chronic hepatitis B (CHB),acute/subacute-on-chronic liver failure (severe hepatitis),and hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC),and to investigate their clinical significances. Methods: A total of 20 healthy controls (control group),33 patients with moderate CHB(moderate CHB group),21 patients with severe CHB(severe CHB group),16 patients with severe hepatitis(severe hepatitis group),16 patients with cirrhosis (cirrhosis group) , and 40 patients with HCC(HCC group) were enrolled.The expression levels of IL-22 mRNA in PBMCs of the subjects in various groups were tested by RT-PCR method;Pearson correlation analysis was used to analyze the relationship between the IL-22 mRNA expression levels and the important clinical indexes. Results: The expression levels of IL-22 mRNA in PBMCs of the patients in moderate CHB,severe CHB and cirrhosis groups were all higher than that in control group(P<0.001);there were no significant differences of the expression levels of IL-22 mRNA of the subjects between severe hepatitis group and control group (P=0.83);the expression level of IL-22 mRNA in PBMCs of the patients in HCC group was lower than that in control group (P<0.001);the expression level of IL-22 mRNA in PBMCs was negatively correlated with the serum total bilirubin(TB) level in severe CHB and severe hepatitis groups(r=-0.383,P=0.043;r=-0.619,P=0.028);the expression level of IL-22 mRNA was positively correlated with the serum alpha-fetoprotein (AFP) level in HCC group (r=-0.664,P=0.000). Conclusion: The decreasing of IL-22 mRNA expression level in the patients with deteriorative hepatitis suggests the dysfunction of liver regeneration;the IL-22 mRNA expression level,as TB,can reflect the severity of liver injury. IL-22 may have promotion effect on the occurrence and development of HCC.

Key words: interleukin-22, hepatitis B,chronic, carcinoma,hepatocellular

中图分类号:

R512.62

陈洪涛, 杨智, 吴诗品. 慢性乙肝病毒感染各阶段患者外周血单个核细胞中IL-22mRNA的表达水平及其临床意义[J]. 吉林大学学报(医学版), 2016, 42(03): 551-555.

CHEN Hongtao, YANG Zhi, WU Shipin. Expression levels of IL-22 mRNA in PBMCs of patients at different HBV infection phases and their significances[J]. Journal of Jilin University Medicine Edition, 2016, 42(03): 551-555.

参考文献

[1] Dudakov JA,Hanash AM,van den Brink MR.Interleukin-22:immunobiology and pathology[J].Annu Rev Immunol,2015,33:747-785.

[2] Sabat R,Ouyang W,Wolk K.Therapeutic opportunities of the IL-22-IL-22R1 system[J].Nat Rev Drug Discov,2014,13(1):21-38.

[3] Jiang R,Tan Z,Deng L,et al.Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3 [J].Hepatology,2011,54(3):900-909.

[4] Qin S,Ma S,Huang X,et al.Th22 cells are associated with hepatocellular carcinoma development and progression[J].Chin J Cancer Res,2014,26(2):135-141.

[5] Zenewicz LA,Yancopoulos GD,Valenzuela DM,et al.interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation[J].Immunity,2007,27(4):647-659.

[6] Feng D,Kong X,Weng H,et al.Interleukin-22 promotes proliferation of liver stem/progenitor cells in mice and patients with chronic hepatitis B virus infection[J].Gastroenterology,2012,143(1):188-198.

[7] Sertorio M,Hou X,Carmo RF,et al.IL-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections[J].Hepatology,2015,61(4):1321-1331.

[8] Radaeva S,Sun R,Pan HN,et al.Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis:IL-22 is a survival factor for hepatocytes via STAT3 activation[J].Hepatology,2004,39(5):1332-1342.

[9] Brand S,Dambacher J,Beigel F,et al.IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro[J].Am J Physiol Gastrointest Liver Physiol,2007,292(4):G1019-G1028.

[10] Feng D,Wang Y,Wang H,et al.Acute and chronic effects of IL-22 on acetaminophen-induced liver injury[J].J Immunol,2014,193(5):2512-2518.

[11] Matsumoto A,Kanai T,Mikami Y,et al.IL-22-producing RORγt-dependent innate lymphoid cells play a novel protective role in murine acute hepatitis[J].PLoS One,2013,8(4):e62853.

[12] Ki SH,Park O,Zheng M,et al.Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding:role of signal transducer and activator of transcription 3[J].Hepatology,2010,52(4):1291-1300.

[13] Rolla S,Alchera E,Imarisio C,et al.The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice[J].Clin Sci,2016,130(3):193-203.

[14] Chestovich PJ,Uchida Y,Chang W,et al.Interleukin-22:implications for liver ischemia/reperfusion injury[J].Transplantation,2012,93(5):485-492.

[15] Gao B,Wang H,Lafdil F,et al.STAT proteins - key regulators of anti-viral responses,inflammation,and tumorigenesis in the liver[J].J Hepatol,2012,57(2):430-441.